William Ringo, Director at Sangamo Biosciences, holds 23.40K shares in Sensei Biotherapeutics (Ticker: SNSE), holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX), holds 17.46K shares in Assembly Biosciences (Ticker: ASMB).
William Ringo latest transaction was an Uninformative Buy of ―.
What was William Ringo's most profitable transaction?
William Ringo’s most profitable transaction was an Informative Sell of SGMO stock on January 6, 2015. The return on the trade was 44.40%.
What is William Ringo's role in Sangamo Biosciences?
William Ringo's role in Sangamo Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.